Clint Sever - 08 Nov 2022 Form 4 Insider Report for Cue Health Inc.

Role
Chief Product Officer
Signature
/s/ Erica Palsis, Attorney-in-Fact for Clint Sever
Issuer symbol
N/A
Transactions as of
08 Nov 2022
Net transactions value
-$290,104
Form type
4
Filing time
10 Nov 2022, 20:03:07 UTC
Previous filing
27 Oct 2022
Next filing
25 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLTH Common Stock Options Exercise $5,333 +26,664 +0.67% $0.2000 3,976,944 08 Nov 2022 Direct F1
transaction HLTH Common Stock Sale $101,590 -26,664 -0.67% $3.81* 3,950,280 08 Nov 2022 Direct F1, F2
transaction HLTH Common Stock Options Exercise $5,333 +26,664 +0.67% $0.2000 3,976,944 09 Nov 2022 Direct F1
transaction HLTH Common Stock Sale $99,457 -26,664 -0.67% $3.73* 3,950,280 09 Nov 2022 Direct F1, F3
transaction HLTH Common Stock Options Exercise $5,333 +26,664 +0.67% $0.2000 3,976,944 10 Nov 2022 Direct F1
transaction HLTH Common Stock Sale $105,056 -26,664 -0.67% $3.94* 3,950,280 10 Nov 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLTH Employee Stock Option (right to buy) Options Exercise $0 -26,664 -11% $0.000000 213,400 08 Nov 2022 Common Stock 26,664 $0.2000 Direct F1, F5
transaction HLTH Employee Stock Option (right to buy) Options Exercise $0 -26,664 -12% $0.000000 186,736 09 Nov 2022 Common Stock 26,664 $0.2000 Direct F1, F5
transaction HLTH Employee Stock Option (right to buy) Options Exercise $0 -26,664 -14% $0.000000 160,072 10 Nov 2022 Common Stock 26,664 $0.2000 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were automatically effected pursuant to a rule 10b5-1 trading plan adopted on June 6, 2022 and established by the reporting person for the purpose of an orderly sale of shares related to the exercises of options scheduled to expire on December 31, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.73 to $3.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.67 to $3.78, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.69 to $4.09, inclusive.
F5 Shares subject to the option are fully vested and immediately exercisable.